Literature DB >> 18344695

The salt-avid state of congestive heart failure revisited.

Yelena Selektor1, Karl T Weber.   

Abstract

Congestive heart failure (CHF), a clinical syndrome, comprises a constellation of signs and symptoms whose origins are rooted in a salt-avid state mediated largely by effector hormones of the renin-angiotensin-aldosterone system (RAAS). Stimuli that normally lead to an activation of this circulating neurohormonal system include reduced dietary sodium, upright posture with or without exercise, and thermal stress. These stimuli remain operative in patients with heart failure; however, here renal perfusion is reduced, leading to excessive RAAS activation. This can contribute to an inability to adequately excrete dietary sodium (salt sensitivity). Active Na+ and water retention (salt avidity) account for an initial expansion of intravascular volume and subsequent rise in extravascular volume. Neurohormonal regulation of Na+ excretion therefore is the pathophysiologic basis for clinical decompensation and the appearance of CHF. By contrast, and despite comparable levels of heart failure, expressed as diastolic or systolic ventricular dysfunction, patients in whom circulating RAAS hormones remain normal are clinically compensated without CHF. Interventions, such as regulated dietary Na+, prolonged bed rest, intermittent periods of semirecumbency (with legs up), water immersion, thermal neutrality, and pharmacologic interference with the generation and activity of RAAS hormones, can be used to attenuate the salt avidity found in patients with CHF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18344695     DOI: 10.1097/MAJ.0b013e3181591da0

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  11 in total

1.  Salt and water imbalance in chronic heart failure.

Authors:  Gaspare Parrinello; Daniele Torres; Salvatore Paterna
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

2.  The dietary quality of persons with heart failure in NHANES 1999-2006.

Authors:  Stephenie C Lemon; Barbara Olendzki; Robert Magner; Wenjun Li; Annie L Culver; Ira Ockene; Robert J Goldberg
Journal:  J Gen Intern Med       Date:  2009-10-31       Impact factor: 5.128

3.  Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via "nongenomic effects".

Authors:  Selma F Mohammed; Tomohito Ohtani; Josef Korinek; Carolyn S P Lam; Katarina Larsen; Robert D Simari; Maria L Valencik; John C Burnett; Margaret M Redfield
Journal:  Circulation       Date:  2010-07-12       Impact factor: 29.690

4.  Sodium restriction in heart failure: benefit or harm?

Authors:  Matthew C Konerman; Scott L Hummel
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-02

Review 5.  BNP and Heart Failure: Preclinical and Clinical Trial Data.

Authors:  Emmanuel E Egom
Journal:  J Cardiovasc Transl Res       Date:  2015-03-14       Impact factor: 4.132

Review 6.  Efficacy and safety of loop diuretic therapy in acute decompensated heart failure: a clinical review.

Authors:  Laura Leto; Nadia Aspromonte; Mauro Feola
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

7.  Feeding the emergence of advanced heart disease in Soweto: a nutritional survey of black African patients with heart failure.

Authors:  Sandra Pretorius; Karen Sliwa; Verena Ruf; Karen Walker; Simon Stewart
Journal:  Cardiovasc J Afr       Date:  2012-06       Impact factor: 1.167

8.  Activation of a novel natriuretic endocrine system in humans with heart failure.

Authors:  Hafid Narayan; Noor Mohammed; Paulene A Quinn; Iain B Squire; Joan E Davies; Leong L Ng
Journal:  Clin Sci (Lond)       Date:  2010-03       Impact factor: 6.124

9.  Empowerment of the rural parents/caregivers of children with heart diseases in Namibia to facilitate coping with the demands of caring at home.

Authors:  Kristofina Amakali; Louis F Small
Journal:  Glob J Health Sci       Date:  2012-12-04

10.  Cardiac Versus Renal Response to Volume Expansion in Preclinical Systolic Dysfunction With PDEV Inhibition and BNP.

Authors:  Siu-Hin Wan; Isabel Torres-Courchoud; Paul M McKie; Joshua P Slusser; Margaret M Redfield; John C Burnett; David O Hodge; Horng H Chen
Journal:  JACC Basic Transl Sci       Date:  2019-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.